Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Neurology · Chronic Inflammatory Demyelinating Polyneuropathy

Recognizing Symptoms and Warning Signs

At a Glance

CIDP usually causes weakness on both sides, numbness or tingling, and reduced reflexes that worsen over 8 weeks or more. Difficulty breathing or swallowing, fainting, confusion, or rapidly spreading weakness requires emergency medical care.

Understanding the symptoms of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is essential for managing your health and knowing when to seek help. While CIDP is a chronic condition that usually develops slowly, it can occasionally present in ways that require immediate medical attention.

The Typical CIDP Timeline

The hallmark of CIDP is its slow progression. Unlike its “acute” cousin, Guillain-Barré Syndrome (GBS), which reaches its worst point within four weeks, typical CIDP progresses over 8 weeks or more [1][2].

In the classic form of the disease, you will likely notice:

  • Symmetrical Weakness: Weakness that affects both sides of the body equally. This usually involves both the proximal muscles (those close to your trunk, like your hips and shoulders) and the distal muscles (those further away, like your hands and feet) [3].
  • Sensory Changes: Numbness, tingling, or a “pins and needles” sensation that often starts in the toes or fingers [4].
  • Reduced Reflexes: Your doctor may find that your deep tendon reflexes (like the “knee-jerk” reflex) are diminished or absent [3].

Acute-Onset CIDP (A-CIDP)

In about 5% of cases, CIDP can begin very suddenly, mimicking GBS [5]. This is called Acute-Onset CIDP (A-CIDP). Doctors distinguish A-CIDP from GBS by watching the timeline: if a patient is initially diagnosed with GBS but their symptoms continue to progress beyond 8 weeks, or if they experience repeated treatment-related fluctuations, their neurologist may reconsider the diagnosis as A-CIDP [6][5]. This requires clinical evaluation and is not something a patient should try to self-diagnose just by counting relapses.

When to Seek Emergency Care

Most of the time, CIDP is not an emergency. It is normal to have “good days” and “bad days,” and a slow, steady progression of mild weakness or sensory changes is the typical course of the disease. A predictable “wear-off” right before your next infusion warrants a call to your clinic, but not an ambulance. However, in cases of severe GBS or rapidly progressing A-CIDP, the immune system can affect the nerves responsible for breathing and swallowing.

Emergency Warning Signs

Seek immediate emergency medical care (call your local emergency number or go to the nearest emergency room) if you experience any of the following:

  • Respiratory Failure: Extreme shortness of breath, difficulty breathing while lying flat, or an inability to take a deep breath. Do not wait for a specific threshold or try to “test” your breathing at home; if you are struggling to breathe, get help now [7][8].
  • Bulbar Dysfunction: Difficulty swallowing (choking on food or saliva), a “wet” or hoarse voice, or a very weak cough that makes it hard to clear your throat [9].
  • Severe Dysautonomia: Signs that your automatic body functions are failing, such as fainting, extreme swings in blood pressure, a dangerously fast or slow heart rate, or severe confusion [5][8].
  • Rapid Paralysis: An inability to walk, new frequent falls, or a sudden, rapid spread of weakness to your face, arms, or torso [5].

Monitoring Your Risk

If you are hospitalized in an acute phase of the disease, your medical team will monitor you closely to protect your airway [5]. Regular monitoring of your “vital capacity” (the amount of air you can exhale) and your ability to swallow safely is a standard part of safe hospital care during an acute flare [9].

Remember: while these emergencies are serious, they are less common in established CIDP than in GBS, and they are treatable when caught early in a hospital setting [6].

Common questions in this guide

What symptoms are typical of CIDP?
CIDP commonly causes weakness on both sides of the body, affecting muscles near the trunk and muscles in the hands and feet. Numbness or tingling and reduced or absent reflexes are also common, and symptoms usually worsen gradually over 8 weeks or more.
How is CIDP different from Guillain-Barré syndrome?
The timing of worsening is an important difference: Guillain-Barré syndrome usually reaches its worst point within four weeks, while typical CIDP progresses over eight weeks or longer. A neurologist must interpret the full clinical course; patients should not try to diagnose the difference by counting relapses alone.
Which CIDP symptoms mean I should seek emergency care?
Get emergency help for severe shortness of breath, difficulty breathing when lying flat, choking or trouble swallowing, a wet or hoarse voice, or a very weak cough. Fainting, severe confusion, very fast or slow heart rate, extreme blood-pressure changes, sudden inability to walk, or rapidly spreading weakness also require immediate care.
Can CIDP start suddenly and look like Guillain-Barré syndrome?
Yes. About 5% of people have acute-onset CIDP, which can initially resemble Guillain-Barré syndrome; continued worsening beyond eight weeks or repeated treatment-related fluctuations may prompt a neurologist to reconsider the diagnosis. This distinction requires clinical evaluation and cannot be made safely at home.
Are good days and bad days normal with CIDP?
Day-to-day variation can occur with CIDP, and predictable worsening just before an infusion may be a reason to contact your clinic. New or rapidly worsening weakness, breathing or swallowing problems, or other emergency signs should not be assumed to be a normal fluctuation.
How are breathing and swallowing checked during a severe CIDP episode?
If CIDP is worsening acutely, the hospital team may monitor your airway, vital capacity, and ability to swallow safely. These checks help clinicians recognize breathing or swallowing problems early and provide treatment promptly.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my condition following a 'typical' CIDP pattern, or do I have a 'variant' like the sensory or motor form?
  2. 2.What symptoms should prompt me to call the clinic versus going straight to the emergency room?
  3. 3.How can we tell the difference between a natural fluctuation in my symptoms and a true relapse that requires treatment changes?
  4. 4.What is my 'clinical nadir'—the point where my symptoms were at their worst—and how long did it take to get there?
  5. 5.Should I have my autonomic functions, like heart rate and blood pressure, monitored more closely during this phase?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Tips in navigating the diagnostic complexities of chronic inflammatory demyelinating polyradiculoneuropathy.

    Lewis RA, van Doorn PA, Sommer C

    Journal of the neurological sciences 2022; (443()):120478 doi:10.1016/j.jns.2022.120478.

    PMID: 36368137
  2. 2

    Autoimmune neuropathies: New guidelines and expert insights into clinical decision making.

    van Doorn PA, Sommer C, Rajabally YA

    Journal of the neurological sciences 2025; (479()):125659 doi:10.1016/j.jns.2025.125659.

    PMID: 41308579
  3. 3

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Its Variants.

    Gwathmey K

    Continuum (Minneapolis, Minn.) 2020; (26(5)):1205-1223 doi:10.1212/CON.0000000000000907.

    PMID: 33002999
  4. 4

    European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.

    Van den Bergh PYK, van Doorn PA, Hadden RDM, et al.

    European journal of neurology 2021; (28(11)):3556-3583 doi:10.1111/ene.14959.

    PMID: 34327760
  5. 5

    European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.

    van Doorn PA, Van den Bergh PYK, Hadden RDM, et al.

    European journal of neurology 2023; (30(12)):3646-3674 doi:10.1111/ene.16073.

    PMID: 37814552
  6. 6

    [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].

    Kanbayashi T, Sonoo M

    Brain and nerve = Shinkei kenkyu no shinpo 2015; (67(11)):1388-96 doi:10.11477/mf.1416200311.

    PMID: 26560954
  7. 7

    Mechanical ventilation in Guillain-Barré syndrome.

    Shang P, Zhu M, Baker M, et al.

    Expert review of clinical immunology 2020; (16(11)):1053-1064 doi:10.1080/1744666X.2021.1840355.

    PMID: 33112177
  8. 8

    Outcome of Guillain-Barre syndrome patients with respiratory paralysis.

    Kalita J, Ranjan A, Misra UK

    QJM : monthly journal of the Association of Physicians 2016; (109(5)):319-23 doi:10.1093/qjmed/hcv190.

    PMID: 26475599
  9. 9

    Swallowing and swallowing-breathing interaction as predictors of intubation in Guillain-Barré syndrome.

    Ogna A, Prigent H, Lejaille M, et al.

    Brain and behavior 2017; (7(2)):e00611 doi:10.1002/brb3.611.

    PMID: 28239521

This page is for informational purposes only and does not constitute medical advice. It explains CIDP warning signs; contact your neurologist for personalized guidance, and seek emergency care for breathing or swallowing problems.

Get notified when new evidence is published on polyneuropathy, inflammatory demyelinating, chronic.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.